Engineered strain MG1363-GLP-1 and EcN 1917-GLP-1 that express the GLP-1 have been designed and demonstrated the significant improvement of PD [88, 89], but these two strains are resistant to antibiotics and weakly tolerant of the environment in the gastrointestinal tract
Problem: the last dose from a vial seems weaker Two possible causes
The most common side effects, such as nausea and constipation, are often related to the drug's effect on gastric emptying
A systematic review and meta-analysis of vitamin D and calcium in preventing osteoporotic fractures
Patients taking tamoxifen for breast cancer often face weight gain as a treatment side effect, making GLP-1 medications like tirzepatide an appealing option for metabolic support
A balanced diet, gradual weight changes, and attention to micronutrients can offer meaningful support